Abstract
Introduction
Although type 2 diabetes mellitus (DM) is a global public health problem, the diabetes-associated dermatological (non-infectious) manifestations (DADM) remain poorly understood and under-diagnosed. We aimed to evaluate the prevalence of 7 known DADM in a primary care setting, and their association macro/microvascular complications.
Methods
Cross-sectionnal study included patients consulting in general practice for DM-follow up, from November 2016 to January 2017. Patients aged <18 years old or consulting for other reason than DM follow up were excluded. Each patient were screened for diabetic dermopathy (DD), Huntley’s papules (HP), necrobiosis lipoidica diabeticorum (NL), acanthosis nigricans (AN), cheiroarthropathy (CA, or stiff hand syndrom), scleredema adultorum of Buschke (SB) and bullosis diabeticorum (BD).
Results
213 diabetic patients were included over a period of 3 months. We found a prevalence of 17.8% (38 patients) for DD, 8.5% (18) for HP, 2.8% (6) for NL, 2.3% (5) for AN, 1.9% (4) for CA, 1.4% (3) for SB and 1.4% (3) for BD. DADM seems to be a risk factor for vascular complications (OR 1.97, p ≤ 0.001). Association with vascular involvement was stronger with DD and macroangiopathy (OR 1.86, p ≤ 0.001), and with NL and microangiopathy (OR 9.7, p ≤ 0.001).
Conclusion
In primary care, DM-associated dermatological manifestations present similar prevalence rates to a tertiary care setting, based on litterature. Complete dermatological examination of diabetic patients is essential and could lead to a better overall management of the pathology, as diabetic cutaneous manifestations appear as a sign of vascular involvement.
Similar content being viewed by others
References
World Health Organisation. Global status report on noncommunicable diseases 2014: attaining the nine global noncommunicable diseases targets; a shared responsibility. Geneva: World HealthOrganization; 2014.
World Health Organisation Report on diabetes in the world. 2016
Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.
Mathers CD, Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med 2017;377(1):13–27
Trihan J-E, Laneelle D, Perez-Martin A, Metclafe N, Frances P. Prévalence des manifestations cutanées non infectieuses spécifiques du diabète de type 2 en secteur de soins primaires. Médecine. 2018;14(9):401–6.
Flagothier C, Quatresooz P, Bourguignon R, Piérard-Franchimont C, Piérard GE. Cutaneous Stigmata of Diabetes Mellitus. Rev Med Liege. 2005;60(5‑6):553–9.
Bessis D, Bessis D, Francès C, Guillot B. Diabète sucré. In: Manifestations dermatologiques des maladies d’ organes. Dermatologie et Médecine; 2011. p. 76.1–76.10.
Senet P, Chosidow O. Manifestations cutanéomuqueuses du diabète. EMC - Dermatologie. 2011;6(4):1–8.
Françès C. Peau et diabète: a-t-on vraiment avancé? Réalités Thérapeutiques en Dermatologie - Vénérologie. 2014;237:7–12.
HAS. Guide de parcours de soins : Diabète de type 2 de l’adulte. 2014
Von Reutern G-M, Goertler M-W, Bornstein NM, Del Sette M, Evans DH, Hetzel A, et al. Grading carotid stenosis using ultrasonic methods. Stroke. 2012;43(3):916–21.
Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–36.
Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63(1):225–32.
Doshi SM, Friedman AN. Diagnosis and Management of Type 2 Diabetic Kidney Disease. CJASN. 2017;12(8):1366–73.
Fournier C, Chabert A, Mosnier-Pudar H, Aujoulat I, Fagot-Campagna A, Gautier A ENTRED Study 2007-2010. 2011
Kusnik-Joinville O, Weill A, Ricordeau P, Allemand H. Diabète traité en France en 2007: un taux de prévalence proche de 4% et des disparités géographiques croissantes. BEH. 2008;43(2008):409–13.
Institut de veille sanitaire (France). Prévalence et incidence du diabète, et mortalité liée au diabète en France: synthèse épidémiologique. Saint-Maurice: Institut de veille sanitaire; 2010.
Logue J, Walker JJ, Colhoun HM, Leese GP, Lindsay RS, McKnight JA, et al. Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia. 2011;54(12):3003–6.
Ricci P, Blotière P-O, Weill A, Simon D, Tuppin P, Ricordeau P, et al. Diabète traité: quelles évolutions entre 2000 et 2009 en France. Bull Epidemiol Hebd. 2010;42(43):425–31.
Diris N, Colomb M, Leymarie F. Dermatoses non infectieuses au cours du diabète sucré. Ann Dermatol Venereol. 2003;109:1009–14.
Verny C, Noaillon M, Baudry E. Treatment of Elderly Patients with Type 2 Diabetes Mellitus. Rev Prat. 2015;65(8):1046–9.
Fagot-Campagna A, Romon I, Fosse S, Roudier C Prévalence et incidence du diabète, et mortalité liée au diabète en France. Synthèse épidémiologique. Institut de Veille Sanitaire. 2019
McCash S, Emanuel PO. Defining diabetic dermopathy: Defining diabetic dermopathy. J Dermatol. 2011;38(10):988–92.
Melin H. An Atrophic Circumcised Skin Lesion In The Lower Extremities Of Diabetics. Acta Med Scand. 1964;176(Suppl 423):1–75.
Huntley AC. Finger pebbles: A common finding in diabetes mellitus. J Am Acad Dermatol. 1986;14(4):612–7.
Fitzgibbons PG, Weiss A-PC. Hand Manifestations of Diabetes Mellitus. J Hand Surg. 2008;33(5):771–5.
Peyrí J, Moreno A, Marcoval J. Necrobiosislipoidica. Semin Cutan Med Surg. 2007;26(2):87–9.
Kelly WF, Nicholas J, Adams J, Mahmood R. Necrobiosis lipoidica diabeticorum: association with background retinopathy, smoking and proteinuria. A case controlled study. Diabet Med. 1993;10(8):725–8.
Rafalson L, Pham TH, Willi SM, Marcus M, Jessup A, Baranowski T. The association between acanthosis nigricans and dysglycemia in an ethnically diverse group of eighth grade students. Obesity. 2013;21(3):E328–33.
Karadağ AS, You Y, Danarti R, Al-Khuzaei S, Chen W. Acanthosis nigricans and the metabolic syndrome. Clin Dermatol. 2018;36(1):48–53.
Humbert P, Nguyen N. Physiopathology of acanthosis nigricans. Ann Dermatol Venereol. 1998;125(11):851–5.
De Schepper S, Naeyaert J-M. Acanthosis Nigricans. Encyclopédie Médico Chirurgicale. 2006
Cabo HA. Thick skin syndrome in diabetes mellitus. J Eur Acad Dermatol Venereol. 2000;14(2):143–4.
Riad H, Al Ansari H, Mansour K, Al Mannai H, Al Sada H, Abu Shaikha S, et al. Pruritic Vesicular Eruption on the Lower Legs in a Diabetic Female, Pruritic Vesicular Eruption on the Lower Legs in a Diabetic Female. Case Reports in Dermatological Medicine, Case Reports in Dermatological Medicine 2013; 2013:e641416.
Mohanty KC, Singh R, Lyengar B. Bullosis Diabeticorum. Indian J Dermatol Venereol Leprol. 1979;45(2):119–21.
Ghosh S, Bandyopadhyay D, Chatterjee G. Bullosisdiabeticorum: a distinctive blistering eruption in diabetes mellitus. Int J Diabetes Dev Ctries. 2009;29(1):41.
Cole GW, Headley J, Skowsky R. Scleredema Diabeticorum: A Common and Distinct Cutaneous Manifestation of Diabetes Mellitus. Diabetes Care. 1983;6(2):189–92.
Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus: a review. Endocrinol Metab Clin North Am. 2013;42(4):869–98.
Sattar MA, Diab S, Sugathan TN, Sivanandasingham P, Fenech FF. Scleroedema Diabeticorum: a Minor but Often Unrecognized Complication of Diabetes Mellitus. Diabet Med. 1988;5(5):465–8.
Verrotti A, Chiarelli F, Amerio P, Morgese G. Necrobiosis Lipoidica Diabeticorum in Children and Adolescents: A Clue for Underlying Renal and Retinal Disease. Pediatr Dermatol. 1995;12(3):220–3.
Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease an update. Hypertension. 2001;37(4):1053–9.
Boursier V, Lazareth I, Pernes J-M, Dadon M, Priollet P. Artériopathie du diabétique : les clés de la prise en charge. Sang Thrombose Vaisseaux. 2001;13(10):599–607.
Houck GM, Morgan MB. A reappraisal of the histologicfindings of pigmented pretibial patches of diabetes mellitus. J Cutan Pathol. 2004;31(2):141–4.
Barrett SC, Huffman FG, Johnson P, Campa A, Magnus M, Ragoobirsingh D. A cross-sectionalstudy of Jamaican adolescents’ risk for type 2 diabetes and cardiovascular diseases. BMJ Open. 2013;3(7).
Sibbald C, Reid S, Alavi A. Necrobiosis Lipoidica. Dermatol Clin. 2015;33(3):343–60.
Verrotti A, Chiarelli F, Amerio P, Morgese G. Necrobiosis Lipoidica Diabeticorum in Children and Adolescents: A Clue for Underlying Renal and Retinal Disease. Pediatr Dermatol. 1995;12(3):220–3.
Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum M. Limited Joint Mobility in Childhood Diabetes Mellitus Indicates Increased Risk for MicrovascularDisease. N Engl J Med. 1981;305(4):191–4.
Yosipovitch G, Hodak E, Vardi P, Shraga I, Karp M, Sprecher E, et al. The Prevalence of Cutaneous Manifestations in IDDM Patients and Their Association With Diabetes Risk Factors and Microvascular Complications. Diabetes Care. 1998;21(4):506–9.
Duff M, Demidova O, Blackburn S, Shubrook J. Cutaneous Manifestations of Diabetes Mellitus. Clin Diabetes. 2015;33(1):40–8.
George SM, Walton S. Diabetic dermopathy. Br J Diabetes. 2014;14(3):95.
Mekić S, Jacobs LC, Gunn DA, Mayes AE, Ikram MA, Pardo LM, et al. Prevalence and determinants for xerosis cutis in the middle-aged and elderly population: A cross-sectional study. J Am Acad Dermatol. 2019;81(4):963–969.e2.
Piérard GE, Piérard-Franchimont C, Scheen A. Critical assessment of diabetic xerosis. Expert Opinion on Medical Diagnostics. 2013;7(2):201–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest relevant to this article to disclose.
Financial disclosure
The authors have no financial relationships relevant to this article to disclose.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Highlights
• Diabetes-associated dermatological manifestations (DADM) are frequent and underdiagnosed.
• This study provides prevalence rates of 7 frequent DADM in primary care.
• Prevalence rates in primary care seems similar to available data on tertiary care.
• They are associated with both macro- and microvascular involvement.
Electronic supplementary material
ESM 1
(DOCX 2206 kb)
Rights and permissions
About this article
Cite this article
Trihan, JE., Lanéelle, D., Metcalfe, N. et al. Diabetes-associated dermatological manifestations in primary care and their association with vascular complications. J Diabetes Metab Disord 19, 989–996 (2020). https://doi.org/10.1007/s40200-020-00594-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40200-020-00594-1